Plasma pre beta1-HDL level is elevated in unstable angina pectoris

Jun Tashiro1, Osamu Miyazaki, Yoshitake Nakamura

  • 1Department of Internal Medicine, Matsudo City Hospital, 4005, Kamihongo, Matsudo, Chiba 271-8511, Japan.

Atherosclerosis
|December 5, 2008
PubMed

Insights

Elevated pre beta1-HDL levels indicate a higher risk of coronary artery disease (CAD). This minor HDL subfraction is significantly higher in unstable angina pectoris patients, suggesting its utility in identifying advanced atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Biochemistry

Background:

  • Pre beta1-HDL, a minor high-density lipoprotein (HDL) subfraction, is crucial for reverse cholesterol transport.
  • Elevated plasma pre beta1-HDL levels are linked to coronary artery disease (CAD) and dyslipidemia.
  • Understanding the clinical significance of pre beta1-HDL is essential for cardiovascular risk assessment.

Purpose of the Study:

  • To investigate the clinical significance of plasma pre beta1-HDL levels in patients with CAD.
  • To compare pre beta1-HDL levels between CAD patients (stable and unstable) and controls.
  • To determine if pre beta1-HDL levels correlate with the atherosclerotic phase of CAD.

Main Methods:

  • Quantification of plasma pre beta1-HDL levels using a specific monoclonal antibody immunoassay (Mab55201).
  • Study included 112 CAD patients (76 stable CAD, 36 unstable angina pectoris) and 30 controls.
  • Analysis performed on both general patient groups and after excluding dyslipidemic subjects.

Main Results:

  • CAD patients exhibited significantly higher mean pre beta1-HDL levels compared to controls (34.8 vs. 26.6 mg/L, p<0.001).
  • Unstable angina pectoris subgroup showed markedly higher pre beta1-HDL levels than the stable CAD subgroup (43.1 vs. 30.9 mg/L, p<0.0001).
  • These associations persisted even after excluding individuals with dyslipidemia.

Conclusions:

  • Elevated plasma pre beta1-HDL levels are associated with the atherosclerotic progression in CAD.
  • Pre beta1-HDL may serve as a valuable biomarker for identifying patients with unstable angina pectoris.
  • Further research can explore pre beta1-HDL's role in risk stratification and therapeutic strategies for CAD.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...